Pharmacological Probes in Primate Social Behavior

  • R. Francis SchlemmerJr.
  • Jennifer E. Young
  • John M. Davis


The appropriateness of interaction with other individuals constitutes a significant factor in the determination of the diagnosis and treatment response in major psychiatric categories. Therefore, animal models of these disorders which include evaluation of social behavior add an important dimension to the model. Non-human primates have been used as subjects in most social studies because of their well documented social structure and noted behavioral similarities to humans.


Squirrel Monkey Fusaric Acid Vervet Monkey Pigtail Macaque Opiate Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Angrist BM, Sathananian G, Wilk S, Gershon S (1974): Amphetamine psychosis: Behavioral and biochemical aspects. J Psychiatr Res 11:13–23PubMedCrossRefGoogle Scholar
  2. Bellarosa A, Bedford J, Wilson MC (1980): Sociopharmacology of d-Amphetamine in Macaca arctoides. Pharmacol Biochem Behav 13:221–228CrossRefGoogle Scholar
  3. Boelkins RC (1979): Effects of parachlorophenylalanine on the behavior of monkeys. In: Serotonin and Behavior, Barchas J, Usdin E, eds. New York: Academic PressGoogle Scholar
  4. Burki HR, Eichenberger E, Sayers AC (1975): Clozapine and the dopamine hypothesis of schizophrenia: A critical appraisal. Pharmakopsychiatr Neuropsychopharmakol 8:115–121PubMedGoogle Scholar
  5. Connell PH (1958): Amphetamine psychosis. Maudsley Monographs No.5. London Oxford UniversityGoogle Scholar
  6. Crowley TJ, Stynes AJ, Hydinger M, Kaufmann IC (1974): Ethanol, metham-phetamine, pentobarbital, morphine, and monkey social behavior. Arch Gen Psychiatry 31:829–838PubMedCrossRefGoogle Scholar
  7. Crowley TJ, Stynes AJ, Hydinger M, Feiger A (1975): Monkey motor stimulation and altered social behavior during chronic methadone administration. Psychopharmacology 43:135–144CrossRefGoogle Scholar
  8. Dubach MF, Bowden DM (1983): Response to intracerebral dopamine injection as a model of schizophrenic symptomatology. In: Ethopharmacohgy: Primate Models of Neuropsychiatric Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  9. Fabre-Nys C, Meller RE, Keverne EB (1982): Opiate antagonists stimulate affiliative behaviour in monkeys. Pharmacol Biochem Behav 16:653–659PubMedCrossRefGoogle Scholar
  10. Freis ED (1954): Mental depression in hypertensive patients treated for long periods with large doses of reserpine. New Engl J Med 251:1006PubMedCrossRefGoogle Scholar
  11. Garver DL, Schlemmer RF, Jr, Maas JW, Davis JM (1975): A schizophreniform behavioral psychosis mediated by dopamine. Am J Psychiatry 132:33–38PubMedGoogle Scholar
  12. Gold MS, Donabedian RK, Redmond DE Jr (1979): Further evidence for alpha2-adrenergic receptor mediated inhibition of prolactin secretion: The effect of yohimbine. Psychoneuroendocrinology 3:253–260CrossRefGoogle Scholar
  13. Haber S, Berger PA, Barchas PR (1979): The effects of amphetamine on agonistic behaviors in nonhuman primates. In: Catecholamines: Bask and Clinical Frontiers, Usdin E, Kopin IJ, Barchas J, eds. New York: Pergamon PressGoogle Scholar
  14. Kalin NH (1985): Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys. Fed Proc 44:249–253PubMedGoogle Scholar
  15. Kjellberg B, Randrup A (1973): Disruption of social behavior of vervet monkeys (Cercopithecus) by low doses of amphetamines. Pharmakopsychiatria 6:287–293CrossRefGoogle Scholar
  16. Kornetsky C (1977): Animal models: Promises and problems. In: Animal Models in Psychiatry and Neurology, Hanin I, Usdin E, eds. Oxford: Pergamon PressGoogle Scholar
  17. Kraemer GW, Ebert MH, Lake CR, McKinney WT (1983): Amphetamine challenge: Effects in previously isolated rhesus monkeys and implications for animal models of schizophrenia. In: Ethopharmacology: Primate Models of Neuropsychiatrie Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  18. Kraemer GW, McKinney WT (1979): Interactions of pharmacological agents which alter biogenic amine metabolism and depression. J Affective Disord 1:33–54CrossRefGoogle Scholar
  19. Machiyama Y, Utena H, Kikuchi M (1970): Behavioural disorders in Japanese monkeys produced by the long-term administration of methamphetamine. Proc Japan Acad 46:738–743Google Scholar
  20. McKinney WT Jr (1974): Primate social isolation. Arch Gen Psychiatr 31:422–426PubMedCrossRefGoogle Scholar
  21. McKinney WT Jr, Eising RG, Moran EC, Suomi SJ, Harlow JF (1971): Effects of reserpine on the social behavior of rhesus monkeys. Dis Nerv Syst 32:735–741PubMedGoogle Scholar
  22. Meiler RE, Keverne EB, Herbert J (1980): Behavioural and endocrine effects of naltrexone in male talapoin monkeys. Pharmacol Biochem Behav 13:663–672CrossRefGoogle Scholar
  23. Miczek KA (1983): Ethopharmacology: Primate Models of Neuropsychiatrie Disorders. New York: Alan R. LissGoogle Scholar
  24. Miczek KA, Woolley J, Schlisserman S, Yoshimura H (1981): Analysis of amphetamine effects on agonistic and affiliative behavior in squirrel monkeys (Saimari sciureus). Pharmacol Biochem Behav 14:103–107Google Scholar
  25. Miczek KA, Yoshimura J (1982): Disruption of primate social behavior by d-amphetamine and cocaine: Differential antagonism by antipsychotics. Psychopharmacology 76:163–171PubMedCrossRefGoogle Scholar
  26. Miller MH, Geiger E (1976): Dose effects of amphetamine on macaque social behavior: Reversal by haloperidol. Res Commun Psychol Psychiat Behav 1:125–142Google Scholar
  27. Miller RE, Levine JM, Mirsky IA (1973): Effects of psychoactive drugs on nonverbal communication and group behavior in monkeys. J Person Soc Psychol 28:396–405CrossRefGoogle Scholar
  28. New JS, Yevich JP, Temple DL, Jr, New KB, Gross SM, Schlemmer RF Jr, Eison MS, Taylor DP, Riblett LA (1988): Atypical antipsychotic agents: Patterns of activity in a series of 3-substituted-2-pyridinyl-1-piperazine derivatives. J Med Chem 31:618–624PubMedCrossRefGoogle Scholar
  29. Nielsen EB, Eison MS, Lyon M, Iversen SD (1983): Hallucinatory behaviors in primates produced by around-the-clock amphetamine treatment for several days via implanted capsules. In: Ethopharmacology: Primate Models of Neuropsychiatric Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  30. Peroutka SJ, Snyder SH (1980): Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522PubMedGoogle Scholar
  31. Poignant JC, Avril A (1978): Pharmacological studies on drug acting on the social behavior of the squirrel monkeys. Arzneimittelforsch 28:267–271PubMedGoogle Scholar
  32. Raleigh MJ, Brammer GL, McGuire MT (1983): Male dominance, serotonergic systems, and the behavioral and physiological effects of drugs in vervet monkeys (Cercopithecus aethiops sabaeus). In: Ethopharmacology: Primate Models of Neuropsychiatric Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  33. Raleigh MJ, Brammer GL, McGuire MT, Yuwiler A (1985): Dominant social status facilitates the behavioral effects of serotonergic agonists. Brain Res 348:274–282PubMedCrossRefGoogle Scholar
  34. Raleigh MJ, Brammer GL, Yuwiler A, Flannery JW, McGuire MT, Geller E (1980): Serotonergic influences on the social behavior of vervet monkeys (Cercopithecus aethiops sabaeus). Exp Neurol 68:322–334PubMedCrossRefGoogle Scholar
  35. Raleigh MJ, Buwiler A, Brammer GL, McGuire MT, Geller E, Flannery JW (1981): Peripheral correlates of serotonergically-influenced behaviors in vervet monkeys (Cercopithecus aethiops sabaeus). Psychopharmacology 72:241–246PubMedCrossRefGoogle Scholar
  36. Redmond DE Jr, Hinrichs RL, Mass JW, Kling A (1973): Behavior of free-ranging macaques after intraventricular 6-hydroxydopamine. Science 181:1256–1258PubMedCrossRefGoogle Scholar
  37. Redmond DE, Jr, Maas JW, Kling A, Dekirmenjian H (1971a): Changes in primate social behavior after treatment with alpha-methyl-paratyrosine. Psychosom Med 33:97–113PubMedGoogle Scholar
  38. Redmond DE, Jr, Maas JW, Kling A, Graham CW, Dekirmenjian H (1971b): Social behavior of monkeys selectively depleted of monoamines. Science 174:428–431PubMedCrossRefGoogle Scholar
  39. Ridley RM, Baker HF (1983): Is there a relationship between social isolation, cognitive inflexibility, and behavioral stereotype? An analysis of the effects of amphetamine in the marmoset. In: Ethopharmacology: Primate Models of Neuropsychiatrie Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  40. Schiorring E (1977): Changes in individual and social behavior induced by amphetamine and related compounds in monkeys and man. In: Cocaine and Other Stimulants, Ellinwood EH, ed. New York: Plenum PressGoogle Scholar
  41. Schlemmer RF Jr, Casper RC, Narasimhachari N, Davis JM (1979): Clonidine-induced hyperphagia and weight gain in monkeys. Psychopharmacology 61:233–234PubMedCrossRefGoogle Scholar
  42. Schlemmer RF Jr, Casper RC, Elder JK, Davis JM (1981): Hyperphagia and weight gain in monkeys treated with Clonidine. In: Psychopharmacology of Clonidine, Lal H, Fielding S, eds. New York: Alan R. LissGoogle Scholar
  43. Schlemmer RF, Jr, Davis JM (1981b): Evidence for dopamine mediation of submissive gestures in the stumptail macaque monkey. Pharmacol Biochem Behav 14(Suppl. 1):95–102PubMedGoogle Scholar
  44. Schlemmer RF, Jr, Davis JM (1981a): Similarities in the behavioral effects of d-amphetamine and apomorphine in selected members of a primate social colony. In: Recent Advances in Neuropsychopharmacology, Advances in the Bio-Sciences, vol. 31, Angrist B, Burrows GD, Lader M, Lingjaedre O, Sedvall G, Wheatley D, eds. Oxford: Pergamon PressGoogle Scholar
  45. Schlemmer RF, Jr, Davis JM (1983): A comparison of three psychotomimeticinduced models of psychosis in nonhuman primate social colonies. In: Ethopharmacology: Primate Models of Neuropsychiatrie Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  46. Schlemmer, RF Jr, Davis JM (1985): Antagonism of amphetamine-induced behavioral changes by BMY13859–1 in a primate model of psychosis. Neurosci Abst 11:114Google Scholar
  47. Schlemmer RF Jr, Davis JM (1986): A primate model for the study of hallucinogens. Pharmacol Biochem Behav 24:381–392PubMedCrossRefGoogle Scholar
  48. Schlemmer RF Jr, Jackson JA, Preston KL, Bederka JP Jr., Garver DL, Davis JM (1978): Phencyclidine-induced stereotyped behavior in monkeys. Eur J Pharmacol 52:379–384PubMedCrossRefGoogle Scholar
  49. Schlemmer RF Jr, Narasimahachari N, Davis JM (1980): Dose dependent behavioral changes induced by apomorphine in selected members of a primate social colony. J Pharm Pharmacol 32:285–289PubMedCrossRefGoogle Scholar
  50. Scraggs PR, Baker HF, Ridley RM (1979): Interaction of apomorphine and haloperidol: Effects on locomotion and other behavior in the marmoset. Psychopharmacology 66:41–43PubMedCrossRefGoogle Scholar
  51. Scraggs PR, Ridley RM (1979): The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset. Psychopharmacology 62: 41–45PubMedCrossRefGoogle Scholar
  52. Sitaram N, Gershon S (1983): From animal models to clinical testing-promise and pitfalls. Prog Neuropsychopharmacol Biol Psychiatry 7:227–228PubMedCrossRefGoogle Scholar
  53. Smith EO, Byrd LD (1983): Contrasting the effects of d-amphetamine on affiliation and aggression in monkeys. Pharmacol Biochem Behav 20:255–260CrossRefGoogle Scholar
  54. Snyder SH (1972): Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 27:169–179PubMedCrossRefGoogle Scholar
  55. Tennant FS Jr, Rawson RA (1983): Cocaine and amphetamine dependence treated with desipramine. In: Problems of Drug Dependence, 1982, NID A Research Monograph 43, Harris LS, ed. Rockville: PHSGoogle Scholar
  56. Wilson MC, Bailey L, Bedford JA (1983): Effects of subacute administration of amphetamine on food competition in primates. In: Ethopharmacobgy: Primate Models of Neuropsychiatrie Disorders, Miczek KA, ed. New York: Alan R. LissGoogle Scholar
  57. Woolverton WL, Goldberg LI, Ginos JZ (1984): Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678–683PubMedGoogle Scholar
  58. Young JE, Verlangieri AJ, Wilson MC (1986): The effects of Clonidine on food consumption and food competition in male stumptail macaques (Macaca arctoides). Pharmacol Biochem Behav 24:1567–1572PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1989

Authors and Affiliations

  • R. Francis SchlemmerJr.
  • Jennifer E. Young
  • John M. Davis

There are no affiliations available

Personalised recommendations